Tomasz Urasinski
Overview
Explore the profile of Tomasz Urasinski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
577
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bartnik M, Pawlik W, Burzynska B, Wasilewski K, Kamienska E, Urasinski T
Genes (Basel)
. 2025 Jan;
15(12.
PMID: 39766843
Background: Hexokinase (HK) deficiency is a rare autosomal recessively inherited disease manifested by chronic nonspherocytic hemolytic anemia. Most patients present with a mild to severe course of the disease (fetal...
2.
Pawinska-Wasikowska K, Czogala M, Bukowska-Strakova K, Surman M, Rygielska M, Ksiazek T, et al.
Front Pediatr
. 2024 Nov;
12:1482720.
PMID: 39483533
Background: A personalised approach to the treatment of acute myeloid leukemia (AML) in children and adolescents, as well as the development of supportive therapies, has significantly improved survival. Despite this,...
3.
Styczynski J, Czyzewski K, Demidowicz E, Wozniak M, Plonowski M, Sawicka-Zukowska M, et al.
Leuk Lymphoma
. 2024 Oct;
66(2):333-336.
PMID: 39412390
No abstract available.
4.
Morawiak A, Salamonowicz-Bodzioch M, Krolak A, Kalwak K, Owoc-Lempach J, Kowalczyk J, et al.
Cancers (Basel)
. 2024 Aug;
16(15).
PMID: 39123368
Purpose: This study aimed to identify the risk factors for acute pancreatitis (AP) and its impact on outcomes in Polish children treated for ALL. Methods: The study group included 2303...
5.
Sekowska A, Czyzewski K, Jaremek K, Zalas-Wiecek P, Zajac-Spychala O, Wachowiak J, et al.
J Clin Med
. 2024 Jul;
13(14).
PMID: 39064118
is a nosocomial pathogen that causes severe infections in immunocompromised patients. The aim of the study was to conduct a microbiological and clinical analysis of infections in children with malignancies...
6.
Pawinska-Wasikowska K, Czogala M, Bukowska-Strakova K, Surman M, Rygielska M, Ksiazek T, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539480
Background: The reports of studies that compare the survival of adolescents and young adults with younger children with acute myeloid leukemia (AML) are contradictory. Patients And Methods: We retrospectively analyzed...
7.
Samborska M, Skalska-Sadowska J, Achkar R, Wachowiak J, Derwich K, Czogala M, et al.
Contemp Oncol (Pozn)
. 2024 Feb;
27(4):249-254.
PMID: 38405205
Introduction: This study aimed to present the clinical features and results of treatment of patients diagnosed with refractory or relapsed acute myeloid leukaemia (AML) in Polish Paediatric Leukaemia/Lymphoma Study Group...
8.
Pawinska-Wasikowska K, Czogala M, Skoczen S, Surman M, Rygielska M, Ksiazek T, et al.
Front Immunol
. 2024 Jan;
14:1268993.
PMID: 38187390
Background: Gemtuzumab ozogamicin (GO), one of the first targeted drugs used in oncology, consists of an anti-cluster of differentiation 33 (CD33) monoclonal antibody bound to a derivative of cytotoxic calicheamicin....
9.
Zawitkowska J, Drabko K, Lejman M, Kowalczyk A, Czyzewski K, Dziedzic M, et al.
Sci Rep
. 2023 Dec;
13(1):22619.
PMID: 38114744
The most common complications related to the treatment of childhood acute lymphoblastic leukemia (ALL) are infections. The aim of the study was to analyze the incidence and mortality rates among...
10.
Czogala M, Czogala W, Pawinska-Wasikowska K, Ksiazek T, Bukowska-Strakova K, Sikorska-Fic B, et al.
Cancers (Basel)
. 2023 Sep;
15(18).
PMID: 37760526
Background: The FMS-like tyrosine kinase 3 (FLT3) gene mutated in 10-15% of pediatric acute myeloid leukemia (AML) is associated with an inferior outcome. The aim of the study was to...